{"title":"Actualización en anticoagulantes II: nuevos anticoagulantes orales","authors":"M. C. M. Balosa, R. M. M. Rodríguez","doi":"10.1016/S2172-3761(12)70062-6","DOIUrl":"https://doi.org/10.1016/S2172-3761(12)70062-6","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"104 1","pages":"68-74"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75822849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. A. Iglesias-Iglesias, M. Villagrasa-Salas, V. Llodrá-Ortolá
{"title":"Manual de calidad en Farmacia de Atención Primaria","authors":"A. A. Iglesias-Iglesias, M. Villagrasa-Salas, V. Llodrá-Ortolá","doi":"10.1016/S2172-3761(12)70055-9","DOIUrl":"https://doi.org/10.1016/S2172-3761(12)70055-9","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"14 1","pages":"32-35"},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73934801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. López-Picazo, J. Ruíz, Á. Ariza, Belen Aguilera, J. Sánchez
{"title":"Percepción de los médicos de familia acerca de un programa de ayuda a la prescripción para reducir las interacciones medicamentosas","authors":"J. López-Picazo, J. Ruíz, Á. Ariza, Belen Aguilera, J. Sánchez","doi":"10.1016/S2172-3761(12)70054-7","DOIUrl":"https://doi.org/10.1016/S2172-3761(12)70054-7","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"52 1","pages":"27-31"},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75079145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maria Giner-Soriano, D. Gomez-Ulloa, A. Vila-Bundó, A. Àlvarez-Carrera, F. Montañés-Muñoz
{"title":"Seguridad de los bifosfonatos en el tratamiento de la osteoporosis","authors":"Maria Giner-Soriano, D. Gomez-Ulloa, A. Vila-Bundó, A. Àlvarez-Carrera, F. Montañés-Muñoz","doi":"10.1016/S2172-3761(12)70057-2","DOIUrl":"https://doi.org/10.1016/S2172-3761(12)70057-2","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"46 1","pages":"44-49"},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90717948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. C. Montero-Balosa, R. Fernández-Urrusuno, J. R. Boxó-Cifuentes
{"title":"Estatinas en pacientes sin enfermedad cardiovascular: una revisión crítica","authors":"M. C. Montero-Balosa, R. Fernández-Urrusuno, J. R. Boxó-Cifuentes","doi":"10.1016/S2172-3761(12)70056-0","DOIUrl":"https://doi.org/10.1016/S2172-3761(12)70056-0","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"16 1","pages":"36-43"},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75742517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M.C. Montero-Balosa , R. Fernández-Urrusuno , J.R. Boxó-Cifuentes
{"title":"Estatinas en pacientes sin enfermedad cardiovascular: una revisión crítica","authors":"M.C. Montero-Balosa , R. Fernández-Urrusuno , J.R. Boxó-Cifuentes","doi":"10.1016/S2172-3761(12)70056-0","DOIUrl":"https://doi.org/10.1016/S2172-3761(12)70056-0","url":null,"abstract":"<div><p>It shows a critical review of meta-analysis assessing the efficacy of statins in primary prevention of cardiovascular disease. We searched MEDLINE, EMBASE and Cochrane (period: January 2000 to December 2011) for meta-analysis of randomized trials conducted to study the effect of statins in primary prevention of cardiovascular disease. We used PRISMA statement to evaluate accuracy and reliability of meta-analysis. We selected 9 meta-analysis (mean of patients: 88.006). Five studies found a benefit in mayor cardiovascular events (range of relative risk [RR]: 0.69–0.85). Seven meta-analysis obtained improvement in mayor coronary events (range of RR: 0.61–0.77). There was no agreement between the results of total mortality, coronary mortality and cerebrovascular events. This critical review of meta-analysis suggests a modest benefit of statins in a primary prevention set-up.</p></div>","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"10 2","pages":"Pages 36-43"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(12)70056-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71815619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Revisión del tratamiento farmacológico de la urolitiasis","authors":"R. Martínez Pérez","doi":"10.1016/S2172-3761(12)70052-3","DOIUrl":"https://doi.org/10.1016/S2172-3761(12)70052-3","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"10 1","pages":"18-24"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(12)70052-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71829316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Actualización en anticoagulantes II: nuevos anticoagulantes orales","authors":"M.C. Montero Balosa , R.M. Moya Rodríguez","doi":"10.1016/S2172-3761(12)70062-6","DOIUrl":"https://doi.org/10.1016/S2172-3761(12)70062-6","url":null,"abstract":"<div><p>It shows a review of the new oral anticoagulants (dabigatran, rivaroxaban and apixaban). The paper evaluates the efficacy, safety and effectiveness of these drugs, including comparatively, and in relation to the classical K antagonists anticoagulants (warfarin and acenocumarol). Establishing the place of new oral anticoagulants in therapy based on patient characteristics and taking into account the risks and benefits associated with these new treatments, which have yet to be fully informed of its safety profile.</p></div>","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"10 3","pages":"Pages 68-74"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(12)70062-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71863959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"El uso correcto de los medicamentos y la sostenibilidad del Sistema Nacional de Salud","authors":"Juan Carlos Morales Serna","doi":"10.1016/S2172-3761(12)70048-1","DOIUrl":"https://doi.org/10.1016/S2172-3761(12)70048-1","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"10 1","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(12)70048-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71829320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A.A. Iglesias-Iglesias , M. Villagrasa-Salas , V. Llodrá-Ortolá
{"title":"Manual de calidad en Farmacia de Atención Primaria","authors":"A.A. Iglesias-Iglesias , M. Villagrasa-Salas , V. Llodrá-Ortolá","doi":"10.1016/S2172-3761(12)70055-9","DOIUrl":"https://doi.org/10.1016/S2172-3761(12)70055-9","url":null,"abstract":"<div><p>Quality management by ISO9001: 2008 lets control and improve of processes in organizations. Our hospital pharmacy department of the health area has a manual of quality; the fact that a primary health care pharmacist (FAP) was included in the staff, meant the development and implementation of the quality procedures about their work in drug therapy management in the ambulatory care area, establishing documents and indicators as needed. The Integrated Management System of the hospital (SIG: quality, environment and prevention) and, in particular, the quality management system, allows us to go beyond the simple tasks, as it seeks the continuous improvement of procedures and activities.</p></div>","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"10 2","pages":"Pages 32-35"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(12)70055-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71815621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}